Scientists have developed the first non-antibiotic drug to successfully treat tuberculosis in animals. The team hope the compound -developed after 10 years of painstaking research will be trialed on humans within three to four years
Today, the American Thoracic Society joined U.S. Senators Sherrod Brown (D-OH) and Todd Young (R-IN) and other senators in calling on the Trump administration to show leadership in global TB elimination efforts. Senators Brown and Young sent a bipartisan letter to President Trump urging the Administration to provide robust commitments, including for TB control and research and development programs, during the United Nations General Assembly's (UNGA) High-Level Meeting on Tuberculosis.
Many of the vaccines critically needed to fight some of the world's most prevalent infectious diseases are not likely to be developed, a new analysis of current candidates in the research and development pipeline has found.
Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study. These findings may precipitate a complete overhaul of worldwide TB treatment guidelines.
